Dr Reddy's to resubmit application for trials of Russian vaccineAn expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase 2 and phase 3 human clinical trials for the Russian vaccine against COVID-19, Sputnik V, in India, sources said Monday.The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine.2) Bharat Biotech’s Covid-19 vaccine to use ViroVax’s adjuvant for longer-lasting immunityVaccines major Bharat Biotech on Monday announced its coronavirus disease (Covid-19) vaccine Covaxin will use.